Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125534871 | 12553487 | 1 | I | 201505 | 20150619 | 20160713 | 20160713 | PER | US-PERRIGO-15US006369 | PERRIGO | 82.35 | YR | F | Y | 51.25000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125534871 | 12553487 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | U | 4EE1250 | 202319 | 15 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||||
| 125534871 | 12553487 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534871 | 12553487 | 3 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534871 | 12553487 | 4 | C | LOVASTATIN. | LOVASTATIN | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534871 | 12553487 | 5 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG | U | UNKNOWN | 0 | ||||||||
| 125534871 | 12553487 | 6 | C | COENZYME Q10 | UBIDECARENONE | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534871 | 12553487 | 7 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | UNK | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125534871 | 12553487 | 1 | Gastrooesophageal reflux disease |
| 125534871 | 12553487 | 2 | Hypothyroidism |
| 125534871 | 12553487 | 3 | Depression |
| 125534871 | 12553487 | 4 | Blood cholesterol increased |
| 125534871 | 12553487 | 5 | Cardiovascular event prophylaxis |
| 125534871 | 12553487 | 6 | Supplementation therapy |
| 125534871 | 12553487 | 7 | Supplementation therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125534871 | 12553487 | Inappropriate schedule of drug administration | |
| 125534871 | 12553487 | Incorrect drug administration duration | |
| 125534871 | 12553487 | No adverse event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125534871 | 12553487 | 1 | 201505 | 0 | ||
| 125534871 | 12553487 | 2 | 2013 | 0 | ||
| 125534871 | 12553487 | 3 | 2014 | 0 | ||
| 125534871 | 12553487 | 6 | 2005 | 0 | ||
| 125534871 | 12553487 | 7 | 2014 | 0 |